Consistent with FDA labeling, clinicians should consider discontinuation if a sustained, clinically relevant increase in resting heart rate occurs
Many patients find it helpful to note the date, site, and any reactions in a medication diary or smartphone app
Vague Manufacturer Details The website selling Honxi lacks basic transparency: No registered company name No physical address No verified customer service contact All signs point to a generic drop-shipping operation using misleading claims to sell an unregulated product
Market Concentration and Competitive Landscape To learn more about this report, Current Events and Their Impact on the GLP-1 Receptor Agonist Market Uncover macros and micros vetted on 75+ parameters: Get instant access to report Market Trends Rising Prevalence of Type 2 Diabetes and Obesity Globally The world is witnessing an alarming surge in the prevalence of type 2 diabetes and obesity, which is a major catalyst for the rapid expansion of the GLP1 receptor agonist market
Patients on GLP-1 drugs who are experiencing a plateau may also want to talk with their doctor about considering a dose adjustment, medication switch or adding an additional drug
